Weekly Digest – October 2026 Weekly Digest – October 2026 08 October 2026: Datroway approved in China for metastatic TNBC ineligible for PD-1/PD-L1 inhibitors Daiichi Sankyo and AstraZeneca announced that Datroway has been approved in China for adults with unresectable […]